130 related articles for article (PubMed ID: 578399)
1. [Long term effects of the treatment of the Graves' disease by 4 different therapeutics (author's transl)].
Mornex R; Quintana J; Chavrier B
Ann Endocrinol (Paris); 1977; 38(4):273-82. PubMed ID: 578399
[TBL] [Abstract][Full Text] [Related]
2. [Surgical treatment of Graves' disease : a survey (author's transl)].
Linquette M; Fossati P; Proye C
Ann Endocrinol (Paris); 1980; 41(6):611-3. PubMed ID: 6894682
[TBL] [Abstract][Full Text] [Related]
3. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
4. Influence of prior carbimazole on the outcome of radioiodine therapy in pediatric and adolescent Graves' disease.
Ballal S; Soundararajan R; Singh H; Garg A; Chopra S; Bal C
Nucl Med Commun; 2015 Jun; 36(6):566-72. PubMed ID: 25757198
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
[TBL] [Abstract][Full Text] [Related]
6. Hypothyroidism after iodine-131 or surgical therapy for Graves' disease hyperthyroidism.
Gómez JM; Gómez N; Amat M; Biondo S; Rafecas A; Jaurrieta E; Soler J
Ann Endocrinol (Paris); 2000 Sep; 61(3):184-91. PubMed ID: 10970941
[TBL] [Abstract][Full Text] [Related]
7. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
El Refaei SM; Shawkat W
Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
[TBL] [Abstract][Full Text] [Related]
8. [Results of the surgical treatment of Basedow's disease. Apropos of 30 cases].
Abdelmoumene N; Maoui R; El Okby A; Benmiloud M
Ann Endocrinol (Paris); 1982; 43(3):193-202. PubMed ID: 6818892
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of serum LATS activity and hyperfunction and autonomy of the thyroid gland in Graves' disease.
Hennemann G; Dolman A; Docter R; De Reus A; Van Zijl J
J Clin Endocrinol Metab; 1975 Jun; 40(6):935-41. PubMed ID: 1173367
[TBL] [Abstract][Full Text] [Related]
10. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
Hegele RA; Volpé R
J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
[TBL] [Abstract][Full Text] [Related]
11. Long-term results following 131I treatment for Graves' disease in Hong Kong Chinese--discriminant factors predicting hypothyroidism.
Kung AW; Pun KK; Lam KS; Choi P; Wang C; Yeung RT
Q J Med; 1990 Sep; 76(281):961-7. PubMed ID: 2236479
[TBL] [Abstract][Full Text] [Related]
12. Experience with carbimazole in the drug treatment of the hyperthyroidism of Graves' diseases in Nigerians.
Modebe O
East Afr Med J; 1992 Mar; 69(3):153-6. PubMed ID: 1505405
[TBL] [Abstract][Full Text] [Related]
13. Complex investigation of Graves'-Basedow disease: case report.
Luca IC; Bene MC; Cotuţiu C
Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):202-4. PubMed ID: 10756799
[TBL] [Abstract][Full Text] [Related]
14. The adjunctive use of carbimazole during radioactive iodine treatment reduces the cure rate of Graves' disease.
Docrat F; Mokoena T; Karusseit VOL; Ankrah AO
S Afr Med J; 2021 Feb; 111(2):176-179. PubMed ID: 33944730
[TBL] [Abstract][Full Text] [Related]
15. Should radioiodine be the first-line treatment for paediatric Graves' disease?
West JD; Cheetham TD; Dane C; Natarajan A
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):797-804. PubMed ID: 25719296
[TBL] [Abstract][Full Text] [Related]
16. Prediction of outcome in Graves' disease after carbimazole treatment.
Weetman AP; Ratanachaiyavong S; Middleton GW; Love W; John R; Owen GM; Darke C; Lazarus JH; Hall R; McGregor AM
Q J Med; 1986 Apr; 59(228):409-19. PubMed ID: 2875484
[TBL] [Abstract][Full Text] [Related]
17. [Surgical treatment of Basedow's disease. II--Evaluation of 36 subtotal thyroidectomies].
Tran ba Huy P; Levy C; Houlbert D; Amar A; Wassef M; Caporal R; Guillausseau PJ; Segrestaa JM
Ann Otolaryngol Chir Cervicofac; 1984; 101(7):515-22. PubMed ID: 6548888
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic evolution of Graves' disease. Surgical treatment (author's transl)].
Putelat R; Brun JM; Ferry C; Lalloue C
Ann Endocrinol (Paris); 1980; 41(6):606-10. PubMed ID: 6894681
[TBL] [Abstract][Full Text] [Related]
19. Long term thyroid function after subtotal thyroidectomy for Graves' disease.
Busnardo B; Girelli ME; Rubello D; Eccher C; Betterle C
J Endocrinol Invest; 1988 May; 11(5):371-4. PubMed ID: 3183300
[TBL] [Abstract][Full Text] [Related]
20. [Surgical treatment of Graves' disease (author's transl)].
Klioua R; Mornex R; Berthezene F; Fitoussi R
Ann Endocrinol (Paris); 1980; 41(6):614-7. PubMed ID: 6894683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
